The Medicines for Malaria Venture has received its fifth and largest grant of $115 million from the Bill & Melinda Gates Foundation.

Roche has granted Russian start-up Viriom Ltd a licence to develop and commercialise potential novel treatments for HIV/AIDS patients in Russia, Ukraine, Belarus and Kazakhstan.

A £37 million Bioscience Campus is to be set up at GlaxoSmithKline’s site at Stevenage, UK, with funding from the government, GlaxoSmithKline, and other partners.

A new campaign seeks to persuade regulators to set new rules for approving personalised treatments that are currently in clinical development.

Cancer research is not pursuing advances in knowledge likely to have the biggest impact on combating the disease in the next few decades, conference hears.